Medical Ethics In Pediatric Research
Expert-defined terms from the Executive Development Programme in Pediatric Research And Development course at LearnUNI. Free to read, free to share, paired with a professional course.
Able #
bodied Consent – The process by which a parent or legal guardian who is physically and mentally capable provides permission for a child’s participation in research.
Explanation #
The guardian must understand the study’s purpose, procedures, risks, and benefits before agreeing.
Example #
A mother signs a consent form after the researcher explains a vaccine trial for infants.
Practical application #
Researchers schedule a dedicated session to review consent documents and answer questions.
Challenges #
Language barriers, health literacy, and emotional stress may limit true comprehension.
Assent – The affirmative agreement of a child who is capable of understan… #
Assent – The affirmative agreement of a child who is capable of understanding the research, indicating willingness to participate.
Explanation #
Assent is required in addition to parental consent for children who can comprehend age‑appropriate information.
Example #
A 10‑year‑old nods after the researcher describes a blood‑draw study in simple terms.
Practical application #
Use child‑friendly language, visual aids, and a “yes/no” format.
Challenges #
Determining the age or developmental stage at which assent is appropriate and managing dissent.
Beneficence – The ethical principle obligating researchers to maximize po… #
Beneficence – The ethical principle obligating researchers to maximize possible benefits and minimize harms to child participants.
Explanation #
Studies must have a favorable balance of anticipated benefits over potential risks.
Example #
A trial of a new asthma medication offers potential symptom relief that outweighs mild side effects.
Practical application #
Conduct thorough pre‑clinical safety assessments and continuous monitoring.
Challenges #
Quantifying benefits for vulnerable populations and avoiding therapeutic misconception.
Best Interest Standard – The criterion that decisions regarding a child’s… #
Best Interest Standard – The criterion that decisions regarding a child’s participation should prioritize the child’s overall welfare.
Explanation #
Researchers and guardians must evaluate whether enrollment serves the child’s health and development.
Example #
Excluding a child from a study with high procedural pain when the therapeutic gain is minimal.
Practical application #
Ethics committees review protocols against this standard.
Challenges #
Conflicts between parental hopes and objective medical assessments.
Child Assent Form – A document tailored to a child’s comprehension level… #
Child Assent Form – A document tailored to a child’s comprehension level that outlines the study’s purpose, procedures, and rights.
Explanation #
The form uses simple language, pictures, or interactive elements to facilitate understanding.
Example #
A cartoon‑styled booklet for a study on dietary habits in preschoolers.
Practical application #
Pilot test the form with a focus group of children.
Challenges #
Ensuring readability without oversimplifying essential information.
Child Participation – The involvement of children as active contributors… #
Child Participation – The involvement of children as active contributors in research, ranging from data provision to co‑design.
Explanation #
Ethical frameworks encourage respecting children’s agency while safeguarding them.
Example #
Adolescents helping design a questionnaire about mental health.
Practical application #
Include child advisory boards in study planning.
Challenges #
Balancing empowerment with protection from exploitation.
Confidentiality – The duty to protect personal health information of chil… #
Confidentiality – The duty to protect personal health information of child participants from unauthorized disclosure.
Explanation #
Researchers must implement safeguards such as de‑identification and secure storage.
Example #
Encrypting electronic health records used in a longitudinal study.
Practical application #
Train staff on HIPAA‑compliant handling of pediatric data.
Challenges #
Maintaining confidentiality in multi‑site collaborations and during mandatory reporting.
Conflict of Interest – A situation where a researcher’s personal or finan… #
Conflict of Interest – A situation where a researcher’s personal or financial interests could compromise the integrity of the study involving children.
Explanation #
Transparency and management plans are required to prevent bias.
Example #
An investigator holds equity in a company producing the investigational drug.
Practical application #
Institutional review boards (IRBs) require conflict of interest statements.
Challenges #
Detecting subtle influences and ensuring unbiased interpretation of pediatric outcomes.
Continuity of Care – The obligation to provide appropriate medical follow… #
Continuity of Care – The obligation to provide appropriate medical follow‑up for child participants after the research concludes.
Explanation #
Participants should not be left without necessary treatment once the study ends.
Example #
Ensuring children who received an experimental therapy continue to receive it if it proves beneficial.
Practical application #
Include a post‑study care plan in the protocol.
Challenges #
Funding limitations and transitioning from research to routine clinical services.
Data Monitoring Committee (DMC) – An independent group that reviews inter… #
Data Monitoring Committee (DMC) – An independent group that reviews interim data for safety and efficacy in pediatric trials.
Explanation #
The DMC can recommend modification or termination of a study to protect child participants.
Example #
A DMC halts a trial after detecting unexpected cardiac events in adolescents.
Practical application #
Define clear stopping rules in the protocol.
Challenges #
Maintaining blinding while ensuring rapid response to adverse findings.
De‑identification – The process of removing or coding personal identifier… #
De‑identification – The process of removing or coding personal identifiers to protect a child’s privacy in research data.
Explanation #
De‑identified data can be shared more freely while minimizing re‑identification risk.
Example #
Assigning a random ID number to each participant’s laboratory results.
Practical application #
Use secure coding systems and limit key‑holder access.
Challenges #
Balancing data utility with privacy, especially in small pediatric cohorts.
Developmental Capacity – The ability of a child, based on age and cogniti… #
Developmental Capacity – The ability of a child, based on age and cognitive development, to understand and make decisions about research participation.
Explanation #
Researchers assess capacity to determine the need for assent and the level of information provided.
Example #
A 7‑year‑old can grasp the concept of a simple questionnaire but not complex procedures.
Practical application #
Apply standardized tools such as the MacArthur Competence Assessment.
Challenges #
Variability within age groups and cultural differences affecting perceived capacity.
Ethical Review Board (ERB) – A committee, often synonymous with IRB, task… #
Ethical Review Board (ERB) – A committee, often synonymous with IRB, tasked with evaluating the ethical acceptability of pediatric research protocols.
Explanation #
The board assesses risk, consent processes, and compliance with regulations.
Example #
An ERB reviews a study on gene therapy for a rare pediatric disorder.
Practical application #
Submit detailed protocol, consent forms, and risk mitigation strategies.
Challenges #
Ensuring expertise in pediatric ethics and avoiding undue delays.
Ethical Justification – The rationale presented by investigators to demon… #
Ethical Justification – The rationale presented by investigators to demonstrate that a pediatric study meets ethical standards.
Explanation #
Justification must address societal value, scientific necessity, and protection of children.
Example #
A justification that a new vaccine is needed because current options are ineffective in infants.
Practical application #
Include a dedicated section in the protocol narrative.
Challenges #
Articulating abstract benefits and anticipating public scrutiny.
Exclusion Criteria – Specific conditions or characteristics that disquali… #
Exclusion Criteria – Specific conditions or characteristics that disqualify a child from participating in a research study.
Explanation #
Criteria protect vulnerable sub‑populations and ensure data integrity.
Example #
Excluding children with immunodeficiency from a live‑virus vaccine trial.
Practical application #
Screen participants using a checklist during enrollment.
Challenges #
Overly restrictive criteria may limit generalizability and equity.
Family‑Centered Research – An approach that incorporates the family’s per… #
Family‑Centered Research – An approach that incorporates the family’s perspectives, needs, and values into study design and conduct.
Explanation #
Recognizes that children’s health is intertwined with family dynamics.
Example #
Conducting focus groups with parents to refine a pediatric nutrition study.
Practical application #
Invite families to advisory panels and incorporate feedback.
Challenges #
Balancing diverse family opinions and maintaining scientific rigor.
Informed Consent – A process by which a parent or legal guardian voluntar… #
Informed Consent – A process by which a parent or legal guardian voluntarily agrees to a child’s participation after receiving comprehensive information.
Explanation #
Consent must be given without coercion, with adequate time for consideration.
Example #
A guardian signs a consent form after a 30‑minute discussion about a clinical trial.
Practical application #
Provide written, verbal, and visual explanations; assess understanding with teach‑back methods.
Challenges #
Overcoming therapeutic misconception and ensuring consent is not merely a formality.
Institutional Review Board (IRB) – The U #
S. term for an ethics committee that reviews and monitors research involving human subjects, including children.
Explanation #
The IRB must approve protocols, consent documents, and any amendments before enrollment.
Example #
An IRB grants a waiver of assent for a minimal‑risk observational study in neonates.
Practical application #
Maintain ongoing communication for safety reports and protocol changes.
Challenges #
Managing multi‑institutional studies and ensuring consistent standards across sites.
Minimal Risk – A level of risk that is no greater than that encountered i… #
Minimal Risk – A level of risk that is no greater than that encountered in daily life or routine medical examinations of healthy children.
Explanation #
Studies classified as minimal risk may qualify for expedited review.
Example #
Collecting saliva samples for genetic analysis poses minimal risk.
Practical application #
Document comparative risk analysis in the protocol.
Challenges #
Subjectivity in defining “daily life” risks for children with chronic conditions.
Minority Inclusion – The deliberate effort to enroll children from underr… #
Minority Inclusion – The deliberate effort to enroll children from underrepresented racial, ethnic, or socioeconomic groups in research.
Explanation #
Inclusion improves generalizability and addresses health disparities.
Example #
Recruiting African‑American adolescents for a sickle‑cell disease trial.
Practical application #
Partner with community health centers and use culturally appropriate outreach.
Challenges #
Overcoming mistrust, language barriers, and logistical constraints.
Multicenter Pediatric Trial – A research study conducted simultaneously a… #
Multicenter Pediatric Trial – A research study conducted simultaneously at multiple hospitals or clinics involving child participants.
Explanation #
Multicenter designs increase sample size and enhance external validity.
Example #
A phase III trial of a novel anticonvulsant across ten pediatric neurology centers.
Practical application #
Implement a central randomization system and uniform data collection tools.
Challenges #
Harmonizing consent procedures, regulatory requirements, and data monitoring across jurisdictions.
Parental Permission – The authorization given by a parent or guardian for… #
Parental Permission – The authorization given by a parent or guardian for a child’s involvement in research, synonymous with informed consent but emphasizing the guardian’s role.
Explanation #
Must be obtained before any study procedures commence.
Example #
A father signs a permission form for his daughter’s enrollment in a dermatology study.
Practical application #
Verify legal guardianship status and document consent in the participant’s file.
Challenges #
Situations with absent or disputed guardianship and differing cultural expectations.
Parental Proxy Consent – Consent provided by a parent acting on behalf of… #
Parental Proxy Consent – Consent provided by a parent acting on behalf of a child who lacks legal capacity to consent.
Explanation #
The proxy must consider the child’s best interests and any known preferences.
Example #
A mother consents for her infant to receive an investigational antiviral.
Practical application #
Include a proxy consent section in the study’s documentation.
Challenges #
Conflicts when parents disagree or when the child’s assent is withheld.
Patient‑Reported Outcome (PRO) – Data collected directly from children (o… #
Patient‑Reported Outcome (PRO) – Data collected directly from children (or their parents) regarding health status, symptoms, or quality of life.
Explanation #
PROs capture subjective experiences and are valuable for pediatric efficacy assessments.
Example #
A validated pain scale completed by children undergoing chemotherapy.
Practical application #
Use age‑appropriate electronic tablets with built‑in prompts.
Challenges #
Ensuring reliability in younger children and addressing literacy limitations.
Privacy – The right of child participants and their families to control p… #
Privacy – The right of child participants and their families to control personal information and limit intrusion.
Explanation #
Researchers must safeguard both physical and digital privacy throughout the study.
Example #
Conducting home visits with discretion to avoid stigma.
Practical application #
Limit visible study identifiers on participant clothing.
Challenges #
Balancing data collection needs with respect for family privacy.
Protocol Deviation – Any departure from the approved research plan that m… #
Protocol Deviation – Any departure from the approved research plan that may affect participant safety or data integrity.
Explanation #
Deviations must be reported to the IRB and may trigger corrective actions.
Example #
Administering a dose earlier than scheduled due to scheduling constraints.
Practical application #
Implement a tracking log and conduct regular audits.
Challenges #
Distinguishing minor administrative errors from substantive violations.
Protocol Amendment – A formal modification to the research protocol, cons… #
Protocol Amendment – A formal modification to the research protocol, consent documents, or procedures after study initiation.
Explanation #
Amendments require IRB review to ensure continued ethical compliance.
Example #
Adding a new outcome measure midway through a longitudinal study.
Practical application #
Submit a concise amendment package with rationale and impact analysis.
Challenges #
Timing approvals to avoid enrollment delays and managing version control.
Research Ethics Consultation – A service that provides expert advice on e… #
Research Ethics Consultation – A service that provides expert advice on ethical dilemmas encountered in pediatric research.
Explanation #
Consultations aid investigators in navigating complex situations such as consent in emergencies.
Example #
Seeking guidance on enrolling a child with impaired decision‑making capacity after a traumatic injury.
Practical application #
Document consultation outcomes and integrate recommendations into the protocol.
Challenges #
Availability of pediatric ethics expertise and ensuring timely responses.
Risk Assessment – The systematic evaluation of potential harms associated… #
Risk Assessment – The systematic evaluation of potential harms associated with study procedures on child participants.
Explanation #
Determines whether a study meets ethical thresholds for approval.
Example #
Analyzing the likelihood of bruising from a venipuncture in toddlers.
Practical application #
Use validated tools and involve clinical specialists in the assessment.
Challenges #
Predicting rare adverse events and accounting for cumulative risks across multiple procedures.
Risk‑Benefit Ratio – The balance between anticipated benefits to particip… #
Risk‑Benefit Ratio – The balance between anticipated benefits to participants or society and the potential risks incurred by child participants.
Explanation #
A favorable ratio is essential for ethical approval.
Example #
A study offering a novel therapy with a 70 % chance of improvement versus a 5 % risk of mild side effects.
Practical application #
Present quantitative and qualitative data in the IRB submission.
Challenges #
Subjectivity in weighting benefits and risks, especially for rare diseases.
Safety Monitoring Plan – A comprehensive strategy outlining how adverse e… #
Safety Monitoring Plan – A comprehensive strategy outlining how adverse events will be identified, reported, and managed during a pediatric study.
Explanation #
Protects participants by ensuring rapid response to safety signals.
Example #
Immediate reporting of any severe allergic reaction within 24 hours.
Practical application #
Provide training manuals and establish clear communication pathways.
Challenges #
Coordinating across sites and maintaining vigilance in long‑term follow‑up.
Sample Size Calculation – The statistical process used to determine the n… #
Sample Size Calculation – The statistical process used to determine the number of child participants needed to achieve adequate power for detecting an effect.
Explanation #
Must consider ethical implications of enrolling more children than necessary.
Example #
Calculating that 120 participants are required to detect a 15 % improvement in asthma control.
Practical application #
Use software that incorporates pediatric variability and dropout rates.
Challenges #
Limited eligible populations and balancing scientific robustness with participant burden.
Secondary Use of Data – The utilization of data collected in a pediatric… #
Secondary Use of Data – The utilization of data collected in a pediatric study for purposes beyond the original research objectives.
Explanation #
Requires additional consent or a broad consent clause, respecting the child’s future autonomy.
Example #
Re‑analyzing stored genetic samples to explore new biomarkers.
Practical application #
Include a secondary‑use statement in the consent form and obtain parental agreement.
Challenges #
Predicting future research directions and managing consent for minors who may later dissent.
Selective Enrollment – The practice of enrolling only certain sub‑groups… #
Selective Enrollment – The practice of enrolling only certain sub‑groups of children based on specific criteria, potentially leading to bias.
Explanation #
Must be justified ethically to avoid unfair exclusion.
Example #
Recruiting only school‑aged children for a cognitive development study, excluding preschoolers.
Practical application #
Document rationale and consider alternative designs that broaden eligibility.
Challenges #
Ensuring representativeness while maintaining methodological rigor.
Serious Adverse Event (SAE) – An untoward medical occurrence that results… #
Serious Adverse Event (SAE) – An untoward medical occurrence that results in death, is life‑threatening, requires hospitalization, or causes persistent disability in a child participant.
Explanation #
SAEs demand immediate reporting to regulatory authorities and ethics committees.
Example #
A participant experiences a seizure after receiving an investigational drug.
Practical application #
Implement a 24‑hour reporting hotline and detailed case report forms.
Challenges #
Differentiating SAEs related to the study from unrelated medical events.
Standard of Care – The level and type of medical treatment that is genera… #
Standard of Care – The level and type of medical treatment that is generally accepted as appropriate for a particular condition in children.
Explanation #
Control arms in pediatric trials often receive the current standard of care.
Example #
Using inhaled corticosteroids as the comparator in a new asthma medication trial.
Practical application #
Review current guidelines and update protocols accordingly.
Challenges #
Rapidly evolving standards may render a trial outdated before completion.
Surrogate Decision‑Making – The process by which a parent or legal guardi… #
Surrogate Decision‑Making – The process by which a parent or legal guardian makes health‑related choices on behalf of a child who lacks decision‑making capacity.
Explanation #
Surrogates must consider the child’s preferences, when known, and overall welfare.
Example #
Deciding to enroll a toddler in a vaccine study after weighing potential benefits.
Practical application #
Provide decision aids that outline options and possible outcomes.
Challenges #
Emotional stress, cultural expectations, and potential conflicts among multiple guardians.
Therapeutic Misconception – The misunderstanding by participants or paren… #
Therapeutic Misconception – The misunderstanding by participants or parents that the primary purpose of a research study is therapeutic rather than investigational.
Explanation #
Can lead to unrealistic expectations and affect voluntary participation.
Example #
Parents believing a trial will guarantee cure for their child’s rare disease.
Practical application #
Emphasize the experimental nature of interventions during consent discussions.
Challenges #
Overcoming optimism bias and ensuring clarity without discouraging enrollment.
Trial Registration – The public listing of a pediatric research study in… #
Trial Registration – The public listing of a pediatric research study in a recognized registry before participant enrollment begins.
Explanation #
Enhances accountability and reduces selective reporting.
Example #
Registering a phase II oncology trial for children on ClinicalTrials.gov.
Practical application #
Assign a unique identifier and update registry with protocol amendments.
Challenges #
Maintaining up‑to‑date information and meeting different international registration requirements.
Vulnerable Population – A group, such as children, that requires special… #
Vulnerable Population – A group, such as children, that requires special protections due to limited capacity to protect their own interests.
Explanation #
Research involving vulnerable populations is subject to heightened ethical scrutiny.
Example #
Conducting a psychosocial intervention with adolescents in foster care.
Practical application #
Incorporate additional safeguards like independent advocates.
Challenges #
Identifying all aspects of vulnerability, including socioeconomic and cognitive factors.
Waiver of Assent – An IRB‑granted exception allowing a study to proceed w… #
Waiver of Assent – An IRB‑granted exception allowing a study to proceed without obtaining a child’s assent when the research presents minimal risk and obtaining assent is not feasible.
Explanation #
Must be justified with a clear rationale and documented in the protocol.
Example #
Using archived newborn heel‑stick blood samples for a genetic study where contacting infants is impossible.
Practical application #
Include a waiver justification section and describe alternative protections.
Challenges #
Ensuring that the waiver does not undermine respect for the child’s emerging autonomy.
Withdrawal of Participation – The right of a child (when capable) or thei… #
Withdrawal of Participation – The right of a child (when capable) or their guardian to discontinue involvement in a study at any time without penalty.
Explanation #
Must be clearly communicated during the consent process.
Example #
A parent opts to stop a child’s enrollment after the first adverse event.
Practical application #
Provide a simple withdrawal form and outline the process for data removal.
Challenges #
Managing data already collected and maintaining study integrity after withdrawals.
Young Adult Transition – The phase when adolescent participants move from… #
Young Adult Transition – The phase when adolescent participants move from pediatric to adult research settings, requiring ethical consideration of consent and autonomy.
Explanation #
Researchers must re‑evaluate consent status as participants reach legal adulthood.
Example #
A 17‑year‑old in a long‑term cystic fibrosis trial is approached for consent upon turning 18.
Practical application #
Plan for consent re‑assessment in study timelines.
Challenges #
Coordinating with adult research teams and addressing continuity of care.